-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Multiple myeloma (MM) is a clonal plasma cell disease that occurs in old age and is still incurable
Graduate
Attending physician, Department of Hematology, Affiliated Hospital of Jining Medical College
Graduated from the First Affiliated Hospital of Soochow University
Member of the Hematology Professional Committee of Shandong Non-public Medical Institutions Association
Member of the Cell Clinical Research Professional Committee of Shandong Biomedical Engineering Society
Publications: three papers in SCI and one in core journals
Director of the Department of Hematology, Affiliated Hospital of Jining Medical College
Doctor of Medicine Chief Physician Master Supervisor
Hematology Branch of Chinese Medical Association is a member of the 8th Youth Committee
Member of the Experimental Diagnostics Group of the Hematology Branch of the Chinese Medical Association
Member of the Anti-Leukemia Alliance of the Chinese Society of Clinical Oncology (CSCO).
Member of hematology branch of Shandong Medical Association
Deputy Leader of the Transplantation Group of the Hematology Branch of Shandong Medical Association
Member of the Standing Committee of the Hematology Branch of Shandong Medical Doctor Association
The patient was an elderly patient with frail MM with anemia, colon, and ovarian disease, and partial remission (PR) was achieved after induction of therapy from dexamethasone
It can be seen that IRd can be used as a treatment option
Clinical studies have shown that the IRd all-oral regimen can improve the depth of remission in PATIENTS with MM, prolong the survival without progression (PFS)2, and is easy to use and highly accessible, which helps to reduce the discontinuation
References
[1] Dimopoulos MA, et al.
[2] Manda S, et al.
Edited: Moon Reviewer: Janet Typesetting: moly Executive: moly
Click "Read the original article" to see the full content